Introduction
============

Initially discovered in *Caenorhabditis elegans*, microRNAs (miRNAs) have emerged as common cellular components with conserved functions in both animals and plants. In all species, miRNAs associate with Argonaute proteins to form the core--effector complex, known as the miRNA-induced silencing complex (miRISC), which is able to alter protein synthesis and/or induce messenger RNA (mRNA) destabilization. In animals, there are several members of the Argonaute gene family, all of which are essential for small-RNA-mediated silencing pathways (reviewed in [@b17]).

It has been reported that the miRISC can influence translation in distinct ways (reviewed in [@b11]). Interestingly, in *Drosophila*, the identity of the Argonaute protein associated with miRNA can dictate the mechanism that will lead to translational inhibition ([@b19]). This indicates that the Argonaute constituent of the miRISC, as well as its interacting proteins, contribute to regulating protein expression by different mechanisms.

In this study, we identify the receptor for activated C-kinase (RACK1) as an interactor of both *C. elegans* and human miRISC, and demonstrate the importance of RACK1 for miRNA-mediated gene silencing in both systems. We observe that the loss of RACK1 affects the association of miRNA and Argonaute with translating ribosomes, suggesting that this component of the 40S ribosomal subunit can mediate the recruitment of the miRISC to the active site of translation.

Results and Discussion
======================

RACK1 interacts with the miRISC of *C. elegans*
-----------------------------------------------

To gain a better insight into the miRNA pathway, we carried out a two-hybrid screen to identify the proteins that interact with ALG-1; one of the two Argonaute proteins that are essential for miRNA-mediated gene regulation in *C. elegans* ([@b12]). Among the proteins interacting with ALG-1, we identified K04D7.1, the orthologue of the mammalian protein RACK1 ([supplementary Fig S1](#S1){ref-type="supplementary-material"} online). *C. elegans* RACK1 (ceRACK1) has also been identified by mass spectrometry as a constituent of the ALG-1 complex ([@b6]). To confirm the relevance of this interaction, we generated tagged recombinant ALG-1 and ceRACK-1 proteins and performed glutathione *S-*transferase (GST) pulldown assays. When compared with beads coupled to GST protein, we observed that GST-tagged ALG-1 efficiently pulled down His-ceRACK-1 ([Fig 1A](#f1){ref-type="fig"}). This suggests that ceRACK1 is *a bona fide* interactor of ALG-1 in *C. elegans*.

To address whether this interaction can occur *in vivo*, we generated a transgenic worm expressing green fluorescent protein (GFP)∷ALG-1 and haemagglutinin (HA)∷ceRACK-1 to overcome the lack of specific antibodies. Using a whole-worm lysate prepared from the transgenic *C. elegans*, we immunoprecipitated GFP∷ALG-1 with HA∷ceRACK-1 and conversely detected HA∷ceRACK-1 in the GFP∷ALG-1 pulldown ([supplementary Fig S2B](#S1){ref-type="supplementary-material"} online). To determine whether ceRACK-1 can also interact with miRNAs, we used a 2′-*O*-methylated RNA affinity matrix to trap sequence-specific small RNA complexes that are not bound to target mRNAs ([@b18]; [@b36]). By using this method, we found that both ALG-1 and ceRACK-1 are associated with *let-7* and *lin-4* miRNAs ([Fig 1B](#f1){ref-type="fig"}). To determine whether the interaction between ceRACK1 and the miRISC is only a general interaction with the ribosomes, we generated transgenic animals expressing a HA-tagged 40S ribosomal protein. We observed that although the RNase treatment almost abolished the interaction between the *let-7* miRNA complex and the 40S subunit RPS-12 ([Fig 1C](#f1){ref-type="fig"}; [supplementary Fig S2C](#S1){ref-type="supplementary-material"} online), a significant fraction of ceRACK-1 remains associated with the *let-7* complex ([Fig 1C](#f1){ref-type="fig"}). Therefore, our findings provide evidence that free miRISC interacts with the 40S ribosomal subunit, and ceRACK-1 contributes to this interaction.

RACK1 is important for miRNA function in *C. elegans*
-----------------------------------------------------

In *C. elegans*, the miRNA pathway has an important role in the control of animal development. The loss of function of genes associated with this pathway results in pleiotropic phenotypes, probably reflecting their roles in the activity of all *C. elegans* miRNAs ([@b12]; [@b9]; [@b16]; [@b5]). To examine whether *rack-1* is important for the miRNA pathway in *C. elegans*, we depleted *rack-1* in animals using RNA interference (RNAi) feeding delivery (animals carrying loss-of-function alleles of *rack-1* gene are embryonic lethal; data not shown). Although the depletion of the 40S ribosomal subunit *rps-12* leads mostly to embryonic and larval lethality (data not shown), *rack-1*(*RNAi*) shows developmental-timing delay, including heterochronic phenotypes that include defects in adult alae ([Fig 1D--F](#f1){ref-type="fig"}). We also found that a significant proportion of *rack-1*(*RNAi*) animals burst from the vulval opening after L4 moult, a phenotype characteristic of *let-7*-family miRNA mutants ([@b1]: [Fig 1D](#f1){ref-type="fig"}). All these phenotypes are similar to those that we observed in *alg-1*(*RNAi*) animals and are enhanced in *alg-2*(*lf*) single-mutant animals ([Fig 1D](#f1){ref-type="fig"}). The similarity of the phenotypes resulting from the loss of function of *rack-1* and the depletion of core components of the miRNA pathway, the synergy observed with *alg-2*, and the other Argonaute essential for this pathway in *C. elegans* ([@b12]), supports the conclusion that *rack-1* functions in the *C. elegans* miRNA pathway.

To better understand the function of *rack-1* in the miRNA pathway, we decided to monitor the miRNA levels of *C. elegans* that was subjected to *rack-1* RNAi. Although, as reported recently ([@b21]), we observed a significant decrease in the amount of miRNAs in *alg-1*(*RNAi*) animals ([Fig 2A](#f2){ref-type="fig"}), the knockdown of *rack-1* in *C. elegans* led to an increase in *let-7* and *lin-4* miRNA levels ([Fig 2A](#f2){ref-type="fig"}). Interestingly, this accumulation of miRNAs was attenuated in the absence of *alg-1* but was unaffected in *alg-2*(*lf*) animals ([Fig 2B](#f2){ref-type="fig"}). This indicates that the accumulation of miRNAs observed in *rack-1*(*RNAi*) animals requires the Argonaute ALG-1, but not ALG-2.

Although *rack-1* and *alg-1* knockdowns result in similar heterochronic phenotypes ([Fig 1D](#f1){ref-type="fig"}), the opposite effect on miRNA levels suggests that ALG-1 and ceRACK-1 are not functioning at the same point in the miRNA pathway. It is likely that RACK1 is not required for loading and stabilization of miRNAs. The simplest explanation for the accumulation of miRNAs in *rack-1*(*RNAi*) animals is that the lack of RACK1, which causes failed regulation, could result in a slower turnover of assembled miRISCs. Interestingly, it has been reported that the interaction between the miRNA and its mRNA target leads to the degradation of the miRNA ([@b2]). Thus, the accumulation of miRNAs observed in the absence of ceRACK-1 might indicate that a large amount of ALG-1--miRNA complex cannot reach its mRNA target, leading to miRNA accumulation.

RACK1 interacts with the human miRISC
-------------------------------------

Because RACK1 is a highly conserved protein in eukaryotes ([supplementary Fig S3](#S1){ref-type="supplementary-material"} online), we next asked whether RACK1 associates with Argonautes in mammals. Although we detected ribosomal RNAs, the ribosomal 40S subunit RPS3, human Ago2 (hAgo2) and miRNAs such as *let-7* and *miR-21* in the RACK1 immunoprecipitate from HeLa cell lysate, we did not observe an interaction between hAgo1 and RACK1 ([Fig 3](#f3){ref-type="fig"}; [supplementary Fig S2D,E](#S1){ref-type="supplementary-material"} online). This is surprising as hAgo1 is a member of the Argonaute gene family that is able to bind to miRNAs ([@b23]) and is also involved in translational repression. However, the mechanism of its action---which could be different from hAgo2---is not known ([@b31]). The treatment of the samples with RNase A does not abrogate the association between RACK1 and the miRISC, suggesting that part of the interaction is either direct or mediated by other proteins ([Fig 3B](#f3){ref-type="fig"}; [supplementary Fig S2D](#S1){ref-type="supplementary-material"} online). Thus, as observed in *C. elegans*, components of the mammalian miRISC interact *in vivo* with RACK1.

Human miRNA gene silencing requires RACK1
-----------------------------------------

Next, we tested whether RACK1 is required for miRNA-mediated translational repression in mammalian cells. When cells were treated with short-interfering RNA (siRNA)-targeting RACK1, a marked increase in the expression of the endogenous IMP1 and RAS proteins---two characterized *let-7* targets in human cells---was observed ([@b20]; [@b32]; [Fig 4A](#f4){ref-type="fig"}). However, RACK1 knockdown did not alter the steady-state level of IMP1 mRNA, suggesting post-transcriptional regulation ([supplementary Fig S4A](#S1){ref-type="supplementary-material"} online). To demonstrate that the effect of RACK1 on translation requires miRNAs, we carried out dual luciferase assays with a miRNA-regulated reporter construct that contains eight tandem *let-7* sites ([@b19]) and a luciferase reporter that contains part of the *let-7*-targeted HMGA2 3′UTR. The knockdown of RACK1 with three independent siRNAs significantly and specifically altered the expression of both luciferase reporters ([Fig 4B](#f4){ref-type="fig"}; [supplementary Fig S5](#S1){ref-type="supplementary-material"} online). To show that this effect is specific to RACK1, we altered the expression of the human 40S ribosomal subunit RPS3. The knockdown of RPS3 resulted in a general inhibition of translation, without any specific effect on the miRNA-targeted luciferase reporter ([supplementary Fig S6](#S1){ref-type="supplementary-material"} online). Moreover, when we used a reporter that contains three target sites complementary to endogenous *let-7a*, we observed no change in luciferase expression ([supplementary Fig S7](#S1){ref-type="supplementary-material"} online). Therefore, RACK1 seems to be required to mediate miRNA-dependent translational repression, but not for RNAi.

RACK1 RNAi impairs miRISC association with polysomes
----------------------------------------------------

As RACK1 has been identified as a core component of the ribosome (reviewed in [@b27]), we decided to test whether RACK1 contributes to the recruitment of the miRISC to the translational machinery. We carried out sucrose gradient fractionation to monitor distribution of the *let-7* miRNA in *rack-1*(*RNAi*) and *control*(*RNAi*) animals. Although neither the polysome distribution in the *rack-1*(*RNAi*) population ([supplementary Fig S8C](#S1){ref-type="supplementary-material"} online) or the distribution of *let-7* mRNA targets such as *lin-41* and *daf-12* is significantly affected ([@b30]; [@b34]; [@b35]; [@b13]; [Fig 5A](#f5){ref-type="fig"}), the amount of *let-7* miRNA associated with polysomes is reduced, compared with *control*(*RNAi*) animals ([Fig 5A](#f5){ref-type="fig"}; *P*\<0.005).

Human Argonautes have been shown to be associated with polysomes, as their association with heavy fractions is abrogated by puromycin treatment ([@b28]). We also observed that hAgo2 cofractionates with RACK1 on the polysomes, by using the sucrose gradient fractionation approach ([supplementary Fig S2F](#S1){ref-type="supplementary-material"} online). We tested whether the presence of hAgo2 with polysomes requires RACK1. To monitor the amount of hAgo2 associated with ribosomes, we pelleted ribosomal complexes by using a sucrose cushion ([@b15]). Compared with control, the level of hAgo2 copelleted with ribosomes is decreased when RACK1 is depleted by RNAi ([Fig 5B](#f5){ref-type="fig"}; [supplementary Fig S8B](#S1){ref-type="supplementary-material"} online), suggesting that RACK1 contributes to the recruitment of hAgo2 to ribosomes.

This data suggests that RACK1 contributes to miRNA-mediated gene regulation at a post-initiation step. Indeed, RACK1 is a stoichiometric component of the 40S ribosome that is positioned at the exit channel to mediate these types of regulations ([@b33]; [@b8]). This could explain the mechanism by which miRNA regulates target gene expression at the elongation step ([@b29]; [@b22]; [@b26]; [@b24]; [@b28]), and how miRNAs could regulate through target sites in coding regions ([@b14]). In *Saccharomyces cerevisiae*, RACK1 is required to recruit Scp160p to specific mRNAs and thus modulate their translations ([@b3]). These observations and our results suggest that RACK1 functions as an evolutionarily conserved molecular adaptor on ribosomes to recruit a variety of regulators of mRNA translation---such as miRISC---and facilitates their interactions with the translational machinery at diverse steps of translation. The RACK1-dependent miRNA-mediated gene regulation is probably different from canonical GW182-dependent miRNA-mediated gene regulation, and it might also be a fail-safe mechanism that can capture miRNA-targeted mRNAs that escape regulation at the initiation step.

Methods
=======

**Nematode methods.** *C. elegans* strains were grown under standard conditions ([@b4]). Transgenic lines MJS10 and MJS17 were produced by microinjection, as described in [@b25]. RNAi experiments were conducted with synchronized animal populations, as described previously ([@b7]).

***C. elegans* polysome fractionation.** *C. elegans* polysome fractionation was performed as described by [@b10]. Quantitative detection of mRNAs and miRNAs were performed using TaqMan Gene Expression and microRNA Assay kits (Applied Biosystems), respectively.

**Human cells sucrose cushion.** HeLa lysates (lysis buffer: 1% NP-40, 10-mM HEPES (pH 7.4), 150-mM KCl, 5-mM MgCl~2~, 0.25-mM DTT, 50-μM cycloheximide, 0.4-U/μl RNAsin and protease inhibitors) were pretreated with cyclohexamide and spun down (10,000 *g*, 10 min, 4°C), and equivalent amounts of supernatant were layered onto a 0.5-M sucrose cushion. Samples were then spun at 107,400 *g* for 45 min at 4°C in an Optima Max Ultracentrifuge.

**siRNA transfection in human cells.** Cells were plated at 1.25 × 10^5^ per well of a six-well plate. For each well, 200 pmol of siRNA was diluted in 175 μl of Opti-MEM (GIBCO). A volume of 2 μl of oligofectamine (Invitrogen) was diluted in 13-μl Opti-MEM and incubated at 20°C for 5 min. The siRNA mixture and the oligofectamine mixture were mixed and incubated at 20°C for 20 min. The sample was then added to the well and mixed gently. The media were replaced after 4--6 h.

**Supplementary information** is available at EMBO *reports* online (<http://www.emboreports.org>).

Supplementary Material {#S1}
======================

###### Supplementary Material

###### Review Process File

We thank V. Ambros, R. Utley, A. Sobala and members of our laboratories for comments on the manuscript. We also thank G. Meister for hAgo1 and hAgo2 antibodies and E. Paquet for statistical support. Some nematode strains were provided by the *Caenorhabditis* Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. This work was funded by the Wellcome Trust and European Framework 6 SIROCCO consortium fund (G.H.) and the Canadian Institutes of Health Research (CIHR; M.J.S.). S.B. is a participant in the Wellcome Trust PhD programme. G.H. is a Wellcome Trust Career Development fellow and M.J.S. is a CIHR New Investigator.

The authors declare that they have no conflict of interest.

![RACK1 interacts with constituents of *C. elegans* and the human miRISC. (**A**) Recombinant ceRACK-1 interacts with GST-tagged ALG-1. Western blot analysis of GST pulldowns of His-tagged ceRACK-1 incubated with GST or GST-ALG-1 and probed with His antibody. Input represents the equivalent of 10% of the His-RACK1 used for pulldown. (**B**) ceRACK-1 associates with the miRISC in *C. elegans*. Extracts from MJS10 strain were incubated with the *let-7*-complementary (*let-7*), *lin-4*-complementary (*lin-4*) or nonspecific (*ctl*) tethered 2′-*O*-methyl oligonucleotide (2′-*O*-Me oligo). Beads were washed, and bound GFP∷ALG-1 and HA∷ceRACK-1 were detected by western blotting. (**C**) Interaction of ceRACK-1, but not RPS-12, with the miRISC is partly resistant to RNase treatment. Strains expressing tagged proteins were incubated with the *let-7*-complementary or nonspecific (control) tethered 2′*-O-*methyl oligonucleotide. Beads were washed and treated (+) or not (−) with RNase, followed by the detection of GFP∷ALG-1, HA∷ceRACK-1 and HA∷RPS-12 by western blotting. In **B** and **C**, input represents the equivalent of 5% of the total extract incubated with tethered oligonucleotides. Dashed lines indicate that unrelated lanes have been removed between samples. Relative intensities of the signal are shown under each lane in **B** and **C**. (**D**) Knockdown of ceRACK-1 causes heterochronic defects similar to those observed for *alg-1*(*RNAi*). Adult alae defects and bursting vulva were scored on young adult animals fed with bacteria expressing either control, *rack-1* or *alg-1* double-stranded RNA. Developmental (dev.) defects observed include one or more of the following: larval lethality, moulting defects, vulva and gonadal morphogenesis defects. The number (*n*) of animals scored is indicated. Asterisk: as *alg-2*(*lf*); *rack-1*(*RNAi*) animals exhibit severe larval lethality and developmental arrest, sufficient numbers of adult-stage animals could not be obtained to reliably scored vulval bursting; however, alae defects were scored for 60 animals that managed to reach the adult stage. (**E**) Representative adult alae defect (Nomarski optics) observed in *rack-1*(*RNAi*) animals. The white bars show the region of adult cuticles lacking alae or with abnormal alae morphology. Magnification is × 630. (**F**) Extra seam cells (top panel) and defect in seam-cell fusions (arrows; bottom panel) are observed in adult *rack-1*(*RNAi*) animals. The magnification of both pictures is × 1,000. GFP, green fluorescent protein; GST, glutathione *S-*transferase; HA, haemagglutinin; miRISC, miRNA-induced silencing complex; NA, not applicable; ND, not determined; RACK, receptor for activated C-kinase; RNAi, RNA interference; WT, wild type.](embor201166f1){#f1}

![ceRACK-1 affects the level of miRNA in an *alg-1*-dependent manner. (**A**) Although *alg-1*(*RNAi*) reduces miRNA levels, *rack-1*(*RNAi*) leads to an accumulation of miRNAs. (**B**) ALG-1, but not ALG-2, is important to accumulate miRNAs in *rack-1*(*RNAi*) animals. The miRNA levels were measured relative to the small nucleolar RNA (*sn2841*) using quantitative reverse transcription--PCR (TaqMan Assays) in adult animals fed with bacteria expressing either control (*Ctl*), *alg-1* or *rack-1* double-stranded RNA, as indicated. In all RNAi conditions, no significant changes were observed in the level of the control RNA *sn2841* (data not shown). The error bars represent the 95% confidence interval from three independent experiments and a Student\'s two-sided *t-*test was applied on the normalized *C*~t~ values to obtain *P*-values. miRNA, microRNA; RACK, receptor for activated C-kinase; RNAi, RNA interference; Wt, wild type.](embor201166f2){#f2}

![RACK1 interacts with human Ago2 and miRNAs. (**A**) Human RACK1 binds to both Ago2 and miRNAs. RACK1 was immunoprecipitated with monoclonal RACK1 antibody (RACK1) and non-conjugated Protein A beads as a negative control. Input represents the equivalent of 4% of the total extract used for immunoprecipitation. The immunoprecipitate was tested for the presence of RACK1, hAgo2 and hAgo1 by western blotting and *let-7* miRNA by northern hybridization. (**B**) RACK1 interaction with hAgo2 and the miRNA *miR-21* is RNA independent. Immunoprecipitations were performed with mouse monoclonal antibodies raised against RACK1 and GFP (used as a negative control) as indicated. Input represents 10% of total lysate used for the immunoprecipitation. The immunoprecipitates were treated with RNase A for 1 h at 4°C. The supernatant (S) and the immunoprecipitate (B) samples, with or without RNase treatment, were tested for the presence of hAgo2, RACK1 and *miR-21*. GFP, green fluorescent protein; hAgo1/2, human Ago1/2; IP, immunoprecipitation; miRNA, microRNA; RACK, receptor for activated C-kinase; RNAi, RNA interference.](embor201166f3){#f3}

![RACK1 is required for miRNA silencing in human cells. (**A**) RACK1 is required for the silencing of the human IMP1 and RAS. Lysates from RNAi-treated cells were immunoblotted with RACK1, IMP1 and RAS antibodies, as indicated. Tubulin immunoblot acted as a loading control. (**B**) RACK1 affects the translation of a reporter that carries miRNA target sites. Renilla luciferase constructs that contain a 3′UTR with either eight *let-7* miRNA target sites or no *let-7* miRNA target sites were transfected in RNAi-treated HeLa cells. Firefly luciferase was used as an internal control. The graph represents the quantification of the dual luciferase assay from five repeats and the error bars represent standard propagated errors and significance that were analysed with a Student\'s *t-*test. RL:8 *let-7* sites: reporter contains eight tandem *let-7* miRNA target sites. RL:no *let-7* site: reporter without *let-7* miRNA site. Right panel, detection of RACK1 shows the efficiency of the knockdown. Tubulin was used as a loading control. Ctl, control; miRNA, microRNA; RACK, receptor for activated C-kinase; RL, renilla luciferase; RNAi, RNA interference; siRNA, short-interfering RNA.](embor201166f4){#f4}

![RACK1 is important to recruit the miRISC to translating ribosomes. (**A**) The level of *let-7* and *let-7* targets, *lin-41* and *daf-12*, in each fractionation collected from the sucrose gradient was monitored by quantitative reverse transcription--PCR. Mean fold change of *let-7* and mRNA target RNA molecules associated with polysomes fractions of *rack-1*(RNAi) animals relative to animals exposed to control (*ctl*) is shown. Two independent experiments were performed in replicates. Student\'s two-sided *t-*test was used to assess the significance of the polysomal distribution of *let-7* miRNA between *control*(*RNAi*) and *rack-1*(*RNAi*) animals. Before the *t-*test, the Shapiro--Wilk test confirmed that the data were normally distributed. (**B**) Ribosomal proteins were pelleted with a sucrose cushion from HeLa cells that were treated with control or RACK1 siRNAs, and the pellet-associated hAgo2 was quantified and presented as a ratio of the sum of the free and polysome-associated hAgo2. The graph is derived from five independent experiments carried out with three independent RACK1 siRNAs. Error bars represent the standard deviation, and a Student\'s *t-*test was performed to determine the significance of the data. hAgo2, human Ago2; miRNA, microRNA; mRNA, messenger RNA; RACK, receptor for activated C-kinase; RNAi, RNA interference; siRNA, short-interfering RNA.](embor201166f5){#f5}
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